1. Efficacy and safety of brodalumab in patients with generalized pustular psoriasis and psoriatic erythroderma: results from a 52‐week, open‐label study. (1st March 2017) Authors: Yamasaki, K.; Nakagawa, H.; Kubo, Y.; Ootaki, K. Journal: British journal of dermatology Issue: Volume 176:Number 3(2017) Page Start: 741 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of brodalumab in patients with generalized pustular psoriasis and psoriatic erythroderma: results from a 52‐week, open‐label study. (2nd October 2016) Authors: Yamasaki, K.; Nakagawa, H.; Kubo, Y.; Ootaki, K. Journal: British journal of dermatology Issue: Volume 176:Number 3(2017) Page Start: 741 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long‐term clinical safety and efficacy of brodalumab in the treatment of Japanese patients with moderate‐to‐severe plaque psoriasis. (29th June 2016) Authors: Umezawa, Y.; Nakagawa, H.; Niiro, H.; Ootaki, K. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 30:Number 11(2016:Nov.) Page Start: 1957 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗